Limits...
Gynecomastia: Clinical evaluation and management.

Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B - Indian J Endocrinol Metab (2014)

Bottom Line: Gynecomastia was reported to cause an imbalance between estrogen and androgen action or an increased estrogen to androgen ratio, due to increased estrogen production, decreased androgen production or both.Individual treatment requirements can range from simple reassurance to medical treatment or even surgery.The main aim of any intervention is to relieve the symptoms and exclude other etiological factors.

View Article: PubMed Central - PubMed

Affiliation: Departments of Endocrinology and Metabolism, Ataturk Education and Research Hospital, Yildirim Beyazit University, Ankara, Turkey.

ABSTRACT
Gynecomastia is the benign enlargement of male breast glandular tissue and is the most common breast condition in males. At least 30% of males will be affected during their life. Since it causes anxiety, psychosocial discomfort and fear of breast cancer, early diagnostic evaluation is important and patients usually seek medical attention. Gynecomastia was reported to cause an imbalance between estrogen and androgen action or an increased estrogen to androgen ratio, due to increased estrogen production, decreased androgen production or both. Evaluation of gynecomastia must include a detailed medical history, clinical examination, specific blood tests, imaging and tissue sampling. Individual treatment requirements can range from simple reassurance to medical treatment or even surgery. The main aim of any intervention is to relieve the symptoms and exclude other etiological factors.

No MeSH data available.


Related in: MedlinePlus

Hormonal evaluation of gynecomastia
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3987263&req=5

Figure 1: Hormonal evaluation of gynecomastia

Mentions: It is recommended that physicians follow the algorithm for gynecomastia in patients under the age of 50 years, unless one of the atypical criteria shown in Figure 1 is met.[2]


Gynecomastia: Clinical evaluation and management.

Cuhaci N, Polat SB, Evranos B, Ersoy R, Cakir B - Indian J Endocrinol Metab (2014)

Hormonal evaluation of gynecomastia
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3987263&req=5

Figure 1: Hormonal evaluation of gynecomastia
Mentions: It is recommended that physicians follow the algorithm for gynecomastia in patients under the age of 50 years, unless one of the atypical criteria shown in Figure 1 is met.[2]

Bottom Line: Gynecomastia was reported to cause an imbalance between estrogen and androgen action or an increased estrogen to androgen ratio, due to increased estrogen production, decreased androgen production or both.Individual treatment requirements can range from simple reassurance to medical treatment or even surgery.The main aim of any intervention is to relieve the symptoms and exclude other etiological factors.

View Article: PubMed Central - PubMed

Affiliation: Departments of Endocrinology and Metabolism, Ataturk Education and Research Hospital, Yildirim Beyazit University, Ankara, Turkey.

ABSTRACT
Gynecomastia is the benign enlargement of male breast glandular tissue and is the most common breast condition in males. At least 30% of males will be affected during their life. Since it causes anxiety, psychosocial discomfort and fear of breast cancer, early diagnostic evaluation is important and patients usually seek medical attention. Gynecomastia was reported to cause an imbalance between estrogen and androgen action or an increased estrogen to androgen ratio, due to increased estrogen production, decreased androgen production or both. Evaluation of gynecomastia must include a detailed medical history, clinical examination, specific blood tests, imaging and tissue sampling. Individual treatment requirements can range from simple reassurance to medical treatment or even surgery. The main aim of any intervention is to relieve the symptoms and exclude other etiological factors.

No MeSH data available.


Related in: MedlinePlus